| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |